Xi Yang
2Department Of Hematology, No.20 Xishi Road
Nantong, 226001, China
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Case Report: Molecular and immunological insights into primary extramedullary plasmacytoma: discovery of a novel IGH::NFKB1 fusion and its impact on disease progression and treatment.
Journal: Frontiers in immunology
Published: July 11, 2025
Interplay of RNA m6A Modification-Related Geneset in Pan-Cancer.
Journal: Biomedicines
Published: May 31, 2024
Multiple Myeloma Side Population Cells Promote Dexamethasone Resistance of Main Population Cells through Exosome Metastasis of LncRNA SNHG16.
Journal: Journal of oncology
Published: August 25, 2022
Exosomal miR-483-5p in Bone Marrow Mesenchymal Stem Cells Promotes Malignant Progression of Multiple Myeloma by Targeting TIMP2.
Journal: Frontiers in cell and developmental biology
Published: January 26, 2022
Combination of AgNPs and Domiphen is Antimicrobial Against Biofilms of Common Pathogens.
Journal: International journal of nanomedicine
Published: August 16, 2021
Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p.
Journal: Cancer cell international
Published: October 05, 2019
Low-dose bortezomib and dexamethasone as primary therapy in elderly patients with Waldenstrӧm macroglobulinemia.
Journal: European journal of haematology
Published: July 29, 2017
Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells.
Journal: BioMed research international
Published: January 19, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026